Nestec S.a.

Nestac S.a.

Mathilde Fleith

Raymond Bertholet

Junkuan Wang

Pierre Ducret

Gayle Crozier-Willi

Michael Buchanan

Armand Malnoe

Martin Vikas

Anne-Lise Carrie

Edward Fern

A method for preparing a synthetic lipid composition in which the content and the distribution of the fatty acids are similar to those of human milk fat, containing less than 2% by weight of free fatty acids, in which palmitic acid is predominantly at the 2-position of the triacylglycerols and the arachidonic and docosahexaenoic acids are distributed between the 1-, 2- and 3-position and in particular predominantly at the 2-position of the triacylglycerols. The method includes the steps of interesterifying a mixture of specific lipids with a mixture of free fatty acids, followed by removal of excess free fatty acids by partial deacidification utilizing steam distillation under vacuum and then by controlled neutralization of the partially deacidified fat.

Lipid composition for infant formula and method of preparation

Synthetic lipid composition in which the content and the distribution of the fatty acids are similar to those of human milk fat, containing less than 2% by weight of free fatty acids, in which palmitic acid is predominantly at the 2-position of the triacylglycerols and the arachidonic and docosahexaenoic acids are distributed between the 1-, 2- and 3-positions and in particular predominantly at the 2-position of the triacylglycerols.

A milk having a formulated lipid composition wherein the lipids are lipids of lactic and vegetable origin which are, by weight, (i) from 30% to 40% milk fat lipids, (ii) from 30% to 40% of a first oil substance which have an oleic acid content in an amount greater than 60%, and (iii) from 1% to 30% of oil substance which provide n-3 and n-6 polyunsaturated fatty acids and so that triglyceride fatty acids of the lipids comprise 20% to 40% saturated fatty acids of lactic origin, 35% to 60% monounsaturated fatty acids, and 15% to 30% of n-3 and n-6 polyunsaturated in a ratio of n-6 to n-3 fatty acids of from 5:1 to 10:1.

Dietetically balanced milk product

Lipids obtained from blackcurrant seed are used for reducing thrombogenicity of blood vessels in humans.

Reduction of thrombogenicity with lipids of blackcurrant seed

Lipids obtained from blackcurrant seed are used for preventing proliferation and dissemination of cancerous metastases in patients.

Growing community of inventors

La Tour de Peilz, Switzerland

Mathilde Fleith